122 related articles for article (PubMed ID: 2902920)
1. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
Wada Y; Koshino Y; Yamaguchi N
Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
[TBL] [Abstract][Full Text] [Related]
2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
3. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
[TBL] [Abstract][Full Text] [Related]
4. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
Chamorro García L
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
[TBL] [Abstract][Full Text] [Related]
5. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
Friis T; Christensen TR; Gerlach J
Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
[No Abstract] [Full Text] [Related]
6. Insomnia related to biperiden withdrawal in two schizophrenic patients.
Hirose S
Int Clin Psychopharmacol; 2000 Nov; 15(6):357-9. PubMed ID: 11110012
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
Horiguchi J; Nishimatsu O
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
[TBL] [Abstract][Full Text] [Related]
8. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
Baker LA; Cheng LY; Amara IB
Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
[TBL] [Abstract][Full Text] [Related]
9. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
Manos N; Gkiouzepas J; Logothetis J
Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
11. Discontinuing antiparkinson medication in chronic schizophrenics. At what cost to the patient?
Manos N; Gkiouzepas J
Acta Psychiatr Scand; 1981 Jan; 63(1):28-32. PubMed ID: 6112842
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in the treatment of schizophrenia.
Marder SR; Meibach RC
Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
[TBL] [Abstract][Full Text] [Related]
13. Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.
König P; Chwatal K; Havelec L; Riedl F; Schubert H; Schultes H
Neuropsychobiology; 1996; 33(2):80-4. PubMed ID: 8927233
[TBL] [Abstract][Full Text] [Related]
14. Extrapyramidal symptoms associated with alcohol withdrawal.
Shen WW
Biol Psychiatry; 1984 Jul; 19(7):1037-43. PubMed ID: 6477989
[TBL] [Abstract][Full Text] [Related]
15. Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study.
Greil W; Haag H; Rossnagl G; Rüther E
Br J Psychiatry; 1984 Sep; 145():304-10. PubMed ID: 6148119
[TBL] [Abstract][Full Text] [Related]
16. A study of the need for anticholinergic medication in patients treated with long-term antipsychotics.
Caradoc-Davies G; Menkes DB; Clarkson HO; Mullen PE
Aust N Z J Psychiatry; 1986 Jun; 20(2):225-32. PubMed ID: 2876700
[TBL] [Abstract][Full Text] [Related]
17. The cholinolytic biperiden in depression. An acute placebo controlled study.
Beckmann H; Moises HW
Arch Psychiatr Nervenkr (1970); 1982; 231(3):213-20. PubMed ID: 7044340
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
Swainston Harrison T; Perry CM
Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
[TBL] [Abstract][Full Text] [Related]
19. Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
Ota T; Miura I; Kanno-Nozaki K; Hoshino H; Horikoshi S; Fujimori H; Kanno T; Mashiko H; Yabe H
J Clin Psychopharmacol; 2015 Jun; 35(3):304-7. PubMed ID: 25839338
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
Gilbert PL; Harris MJ; McAdams LA; Jeste DV
Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
